a note on u s drug pricing
This is a PDF document titled "A Note on U.S. Drug Pricing.pdf" created in September 2025. It is a detailed technical note prepared for academic discussion at Harvard Business School, analyzing the complex factors influencing prescription drug prices in the United States. The content covers topics such as research and development costs, marketing expenses, the role and market power of pharmacy benefit managers (PBMs), pricing strategies including launch prices and rebates, generic competition, anti-competitive practices, and information asymmetry in the pharmaceutical supply chain. The document includes exhibits, data tables, and a glossary to support the analysis. It is an informative, non-conversational report authored by academic and executive fellows, intended for educational and policy discussion purposes.
Questions this document answers
Lack of transparency hides the true costs and discounts, obscuring fair pricing and allowing stakeholders to manipulate prices to their benefit.